SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/252611"
 

Search: onr:"swepub:oai:gup.ub.gu.se/252611" > Improved Cerebrospi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • van Doorn, Ljcv (author)

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • IOS Press,2017

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/252611
  • https://gup.ub.gu.se/publication/252611URI
  • https://doi.org/10.3233/jad-160668DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Cerebrospinal fluid (CSF) biomarkers may support the diagnosis of Alzheimer's disease (AD). We studied if the diagnostic power of AD CSF biomarker concentrations, i.e., A beta(42), total tau (t-tau), and phosphorylated tau (p-tau), is affected by differences in lateral ventricular volume (VV), using CSF biomarker data and magnetic resonance imaging (MRI) scans of 730 subjects, from 13 European Memory Clinics. We developed a Matlab-algorithm for standardized automated segmentation analysis of T1 weighted MRI scans in SPM8 for determining VV, and computed its ratio with total intracranial volume (TIV) as proxy for total CSF volume. The diagnostic power of CSF biomarkers (and their combination), either corrected for VV/TIV ratio or not, was determined by ROC analysis. CSF A beta(42) levels inversely correlated to VV/TIV in the whole study population (A beta(42): r = -0.28; p < 0.0001). For CSF t-tau and p-tau, this association only reached statistical significance in the combined MCI and AD group (t-tau: r = -0.15; p-tau: r = -0.13; both p < 0.01). Correction for differences in VV/TIV improved the differentiation of AD versus controls based on CSF A beta(42) alone (AUC: 0.75 versus 0.81) or in combination with t-tau (AUC: 0.81 versus 0.91). In conclusion, differences in VV may be an important confounder in interpreting CSF A beta(42) levels.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Gispert, J. D. (author)
  • Kuiperij, H. B. (author)
  • Claassen, Jahr (author)
  • Arighi, A. (author)
  • Baldeiras, I. (author)
  • Blennow, Kaj,1958Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology(Swepub:gu)xbleka (author)
  • Bozzali, M. (author)
  • Castelo-Branco, M. (author)
  • Cavedo, E. (author)
  • Emek-Savas, D. D. (author)
  • Eren, E. (author)
  • Eusebi, P. (author)
  • Farotti, L. (author)
  • Fenoglio, C. (author)
  • Ormaechea, J. F. (author)
  • Freund-Levi, Y. (author)
  • Frisoni, G. B. (author)
  • Galimberti, D. (author)
  • Genc, S. (author)
  • Greco, V. (author)
  • Hampel, H. (author)
  • Herukka, S. K. (author)
  • Liu, Y. W. (author)
  • Llado, A. (author)
  • Lleo, A. (author)
  • Nobili, F. M. (author)
  • Oguz, K. K. (author)
  • Parnetti, L. (author)
  • Pereira, J. (author)
  • Picco, A. (author)
  • Pikkarainen, M. (author)
  • de Oliveira, C. R. (author)
  • Saka, E. (author)
  • Salvadori, N. (author)
  • Sanchez-Valle, R. (author)
  • Santana, I. (author)
  • Scarpini, E. (author)
  • Scheltens, P. (author)
  • Soininen, H. (author)
  • Tarducci, R. (author)
  • Teunissen, C. (author)
  • Tsolaki, M. (author)
  • Urbani, A. (author)
  • Vilaplana, E. (author)
  • Visser, P. J. (author)
  • Wallin, A. K. (author)
  • Yener, G. (author)
  • Molinuevo, J. L. (author)
  • Meulenbroek, O. (author)
  • Verbeek, M. M. (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi (creator_code:org_t)

Related titles

  • In:Journal of Alzheimers Disease: IOS Press56:2, s. 543-5551387-28771875-8908

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view